Xerafy is set to highlight its innovative RAIN RFID labeling solutions tailored for pharmaceutical and healthcare packaging at the AIPIA Innovation Stage during the CPHI South East Asia 2026 event. Scheduled from July 8 to 10 in Bangkok, Thailand, this exhibition will showcase how these advanced RFID technologies can streamline processes in the pharmaceutical industry.
The RFID solutions presented by Xerafy aim to enhance the efficiency of pharmaceutical packaging and medical device traceability, as well as optimize inventory management and visibility across healthcare supply chains. Among the featured products are the XSKIN Gamma, suitable for gamma-sterilized packaging, the MICRO Medical for identifying compact medical devices, and the Metal Skin Delta, which is designed for on-metal healthcare assets and metallized packaging.
With the increasing complexity of pharmaceutical supply chains, the implementation of smart RAIN RFID labels is becoming essential for item-level identification and real-time data acquisition. These technologies facilitate improved product traceability, enhance inventory accuracy, and ensure compliance by integrating physical products with digital records throughout various stages such as manufacturing, sterilization, warehousing, distribution, and healthcare operations.
Xerafy emphasizes that its RFID solutions are specifically engineered for challenging environments where conventional barcode systems may not perform well. This is particularly relevant in scenarios involving bulk handling, dense storage, and regulated healthcare applications. The company’s range includes specialized RFID labels and tags catering to sectors like healthcare, manufacturing, logistics, aerospace, oil and gas, and data centers, among others.
The demonstration at CPHI South East Asia 2026 intends to illustrate how connected packaging and RFID technology can facilitate more efficient supply chains for pharmaceuticals and medical devices, showcasing the potential for significant advancements in the industry.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.
